Page 71 - Migraine, the heart and the brain

referenCes
1 Bigal ME, Kurth T, Santanello N, et al. Migraine and cardiovascular disease: a population-based study. Neurology 2010;74:628–635.
2 Kruit MC, van Buchem MA, Hofman PA, et al. Migraine as a risk factor for subclinical brain lesions. JAMA 2004; 291:427–434.
3 Palm-Meinders IH, Koppen H, Terwindt GM, et al. Structural brain changes in migraine. JAMA 2012;308: 1889–1897.
4 Anzola GP, Magoni M, Guindani M, Rozzini L, Dalla VG. Potential source of cerebral embolism in migraine
with aura: a transcranial Doppler study. Neurology 1999; 52:1622–1625. 3
5 ScherAI,GudmundssonLS,SigurdssonS,etal.Migraineheadacheinmiddleageandlate-lifebraininfarcts. JAMA 2009;301:2563–2570.
6 Del SM, Angeli S, Leandri M, et al. Migraine with aura and right-to-left shunt on transcranial Doppler: a casecontrol study. Cerebrovasc Dis 1998;8:327–330.
7 Kurth T, Schurks M, Logroscino G, Gaziano JM, Buring JE. Migraine, vascular risk, and cardiovascular events in women: prospective cohort study. BMJ 2008; 337:a636.
8 Cabanes L, Mas JL, Cohen A, et al. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than =5 years of age: a study using transesophageal echocardiography. Stroke 1993;24:1865–1873.
9 Hausmann D, Mugge A, Becht I, Daniel WG. Diagnosis of patent foramen ovale by transesophageal echocardiography and association with cerebral and peripheral embolic events. Am J Cardiol 1992;70:668– 672.
10 Post MC, Thijs V, Herroelen L, Budts WI. Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine. Neurology 2004;62:1439–1440.
11 Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Effect on migraine of closure of cardiac right-to- left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 2000;356:1648–1651.
12 Reisman M, Christofferson RD, Jesurum J, et al. Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol 2005;45:493–495.
13 Dowson A, Mullen MJ, Peatfield R, et al. Migraine Intervention with STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 2008;117:1397–1404.
14 Spencer FA, Lopes LC, Kennedy SA, Guyatt G. Systematic review of percutaneous closure versus medical therapy in patients with cryptogenic stroke and patent foramen ovale. BMJ Open 2014;4:e004282.
15 Homma S, Sacco RL. Patent foramen ovale and stroke. Circulation 2005;112:1063–1072.
16 Nozari A, Dilekoz E, Sukhotinsky I, et al. Microemboli may link spreading depression, migraine aura, and patent foramen ovale. Ann Neurol 2010;67:221–229.
17 Sevgi EB, Erdener SE, Demirci M, Topcuoglu MA, Dalkara T. Paradoxical air microembolism induces cerebral bioelectrical abnormalities and occasionally headache in patent foramen ovale patients with migraine. J Am Heart Assoc 2012;1:e001735.
18 Eikermann-Haerter K, Negro A, Ayata C. Spreading depression and the clinical correlates of migraine. Rev Neurosci 2013;24:353–363.
19 Lipton RB, Stewart WF. The epidemiology of migraine. Eur Neurol 1994;34(suppl 2):6–11.
20 Headache Classi cation Committee of the International Headache Society. Classi cation and diagnostic criteria for headache disorders, cranial neuralgias, facial pain. Cephalalgia 1988;8(suppl 7):1–96.
21 Launer LJ, Terwindt GM, Ferrari MD. The prevalence and characteristics of migraine in a population- based cohort: the GEM study. Neurology 1999;53:537–542.
22 LiptonRB,BigalME,DiamondM,FreitagF,ReedML,StewartWF.Migraineprevalence,diseaseburden,and the need for preventive therapy. Neurology 2007;68:343–349.
23 Spencer MP, Moehring MA, Jesurum J, Gray WA, Olsen JV, Reisman M. Power m-mode transcranial Doppler for diagnosis of patent foramen ovale and assessing transcatheter closure. J Neuroimaging 2004;14:342– 349.
Right-to-left shunts and migraine
69